Puma Biotechnology PBYI
NASDAQ PBYI
$9.51 -0.33 (-3.35%)
At close: Oct 2, 2026 · 4:00 PM EDT

Puma Biotechnology (PBYI) Liabilities and Shareholders Equity (2010 - 2026)

Updated

Puma Biotechnology's Liabilities and Shareholders Equity was $192.74 million in Q2 2026, down 1.1% from $194.92 million a year earlier and unchanged from the prior quarter.

Analysis

Puma Biotechnology (PBYI) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

At the end of FY2025, Liabilities and Shareholders Equity at Puma Biotechnology came in at $216.3 million, up 1.4% from FY2024.

  • Liabilities and Shareholders Equity shows a five-year compound annual growth rate of -2.4% (FY2020 to FY2025).
  • In earlier years, Liabilities and Shareholders Equity was $213.33 million in FY2024 (-7.5%), $230.53 million in FY2023 (+3.8%), $222.06 million in FY2022 (-2.0%) and $226.59 million in FY2021 (-7.2%).
  • Quarterly Liabilities and Shareholders Equity has moved between $192.7 million (Q1 2026) and $230.53 million (Q4 2023) over five years.
  • Compared with a year earlier, Liabilities and Shareholders Equity was higher in two of the last eight quarters, with an average decline of 2.7%.
  • The best year-over-year quarter for Liabilities and Shareholders Equity over five years was Q1 2024 (growth of 9.1%); the worst was Q2 2022 (a decline of 25.5%).
  • Per Business Quant data, PBYI's Liabilities and Shareholders Equity in the three quarters before Q2 2026 was $192.7 million (Q1 2026), $216.3 million (Q4 2025) and $202.86 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 142.28 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 201.06 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 135.12 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 129.80 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 115.83 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 95.64 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 49.36 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 201.13 Bn
10 Puma Biotechnology 502.85 Mn 115.49 Mn 44.03 Mn 192.74 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 192.74 Mn
Mar 31, 2026 192.70 Mn
Dec 31, 2025 216.30 Mn
Sep 30, 2025 202.86 Mn
Jun 30, 2025 194.92 Mn
Mar 31, 2025 196.18 Mn
Dec 31, 2024 213.33 Mn
Sep 30, 2024 220.72 Mn
Jun 30, 2024 205.00 Mn
Mar 31, 2024 214.15 Mn
Dec 31, 2023 230.53 Mn
Sep 30, 2023 203.61 Mn
Jun 30, 2023 200.49 Mn
Mar 31, 2023 196.26 Mn
Dec 31, 2022 222.06 Mn
Sep 30, 2022 198.77 Mn
Jun 30, 2022 193.65 Mn
Mar 31, 2022 200.69 Mn
Dec 31, 2021 226.59 Mn
Sep 30, 2021 226.29 Mn
API Access

Puma Biotechnology Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=PBYI&period=max&api_key=YOUR_API_KEY